Skip to main content
Log in

Variability in CKD stage in outpatients followed in two large renal clinics

  • Nephrology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

Chronic kidney disease (CKD) is staged by glomerular filtration rate (GFR). CKD stages sometimes vary between routine office visits, and it is unknown if this impacts renal and patient survival separately from a cross-sectional CKD stage value. We quantified and categorized CKD stage variability in a large group of outpatients and correlated this with clinical and demographic features and with renal and patient survival.

Methods

All estimated GFRs were staged in the first observation period. CKD stages were then categorized as static, improving, worsening, or fluctuating. Logistic regression analysis was performed to identify clinical variables associated with CKD stage variability. Death and dialysis progression rates were then collected and analyzed using Cox proportional regression.

Results

During a 1.1-year observation period, 1,262 patients (mean age 71.25 years) had a mean 5 eGFR’s. CKD stages were static in 60.4%, worsened in 14.4%, improved in 7.4%, and fluctuated in 17.2% of patients. Secondary analysis revealed heavy proteinuria and East Asian ethnicity to be negatively, and diabetes mellitus and previous acute kidney injury to be positively associated with improving CKD stages. Cox proportional regression of 902 patients analyzed 2.3 years later revealed a negative association with improving CKD stage and subsequent need for dialysis.

Conclusions

CKD stage changed in 40% of 1,262 elderly patients when determined 5 times in just over 1 year. Improving CKD stage was the only variability pattern significantly associated with any of the clinical outcomes when assessed 2.3 years later, being unlikely to be linked with subsequent need for dialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047

    Article  PubMed  CAS  Google Scholar 

  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351:1296–1305

    Article  CAS  Google Scholar 

  3. Fried LP, Kronmal RA, Newman AB et al (1998) Risk factors for 5-year mortality in older adults: the cardiovascular health study. JAMA 279:585–592

    Article  PubMed  CAS  Google Scholar 

  4. Shlipak MG, Sarnak MJ, Katz R et al (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Eng J Med 352:2049–2060

    Article  CAS  Google Scholar 

  5. Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Eng J Med 351:1344–1346

    Article  CAS  Google Scholar 

  6. Levey AS, Coresh J, Balk E et al (2003) National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Int Med 139:137–147

    PubMed  Google Scholar 

  7. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Int Med 130:461–470

    PubMed  CAS  Google Scholar 

  8. Foley RN (2010) Temporal trends in the burden of chronic kidney disease in the United States. Curr Opin Nephrol Hyper 19:273–277

    Article  Google Scholar 

  9. Amann B, Tinzmann R, Angelkort B (2003) ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diab Care 26:2421–2425

    Article  CAS  Google Scholar 

  10. Atkins RC, Briganti EM, Lewis JB et al (2005) Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 45:281–287

    Article  PubMed  Google Scholar 

  11. Palmer AT, Lewis J (2010) Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol 74:s72–s77

    Google Scholar 

  12. Levey AS, Greene T, Schluchter MD et al (1993) Glomerular filtration rate measurements in clinical trials. J Am Soc Nephrol 4:1159–1171

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tabo Sikaneta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sikaneta, T., Abdolell, M., Taskapan, H. et al. Variability in CKD stage in outpatients followed in two large renal clinics. Int Urol Nephrol 44, 1461–1466 (2012). https://doi.org/10.1007/s11255-011-9934-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-9934-9

Keywords

Navigation